- Home
- RZLT vs SMTI Comparison
RZLT vs SMTI Comparison
Compare RZLT & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- SMTI
- Stock Information
- Founded
- RZLT 2010
- SMTI 1982
- Country
- RZLT United States
- SMTI United States
- Employees
- RZLT N/A
- SMTI N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- RZLT Health Care
- SMTI Health Care
- Exchange
- RZLT Nasdaq
- SMTI Nasdaq
- Market Cap
- RZLT 292.0M
- SMTI 288.2M
- IPO Year
- RZLT N/A
- SMTI N/A
- Fundamental
- Price
- RZLT $4.87
- SMTI $32.64
- Analyst Decision
- RZLT Strong Buy
- SMTI Strong Buy
- Analyst Count
- RZLT 8
- SMTI 2
- Target Price
- RZLT $11.63
- SMTI $47.00
- AVG Volume (30 Days)
- RZLT 349.3K
- SMTI 28.9K
- Earning Date
- RZLT 02-11-2025
- SMTI 11-12-2024
- Dividend Yield
- RZLT N/A
- SMTI N/A
- EPS Growth
- RZLT N/A
- SMTI N/A
- EPS
- RZLT N/A
- SMTI N/A
- Revenue
- RZLT N/A
- SMTI $78,056,873.00
- Revenue This Year
- RZLT N/A
- SMTI $30.48
- Revenue Next Year
- RZLT N/A
- SMTI $24.07
- P/E Ratio
- RZLT N/A
- SMTI N/A
- Revenue Growth
- RZLT N/A
- SMTI 24.66
- 52 Week Low
- RZLT $0.92
- SMTI $26.00
- 52 Week High
- RZLT $6.19
- SMTI $40.75
- Technical
- Relative Strength Index (RSI)
- RZLT 49.47
- SMTI 43.29
- Support Level
- RZLT $4.47
- SMTI $31.99
- Resistance Level
- RZLT $4.98
- SMTI $33.59
- Average True Range (ATR)
- RZLT 0.33
- SMTI 1.22
- MACD
- RZLT -0.01
- SMTI 0.01
- Stochastic Oscillator
- RZLT 38.10
- SMTI 35.69
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.